Search

everythinglearnresearchcommunity

for

Search:↓

Early diagnosis and surgery can improve symptoms of ovarian hyperthecosis in postmenopausal women.

Leydig cell tumors can cause high testosterone and symptoms like hair loss in postmenopausal women, but surgery can improve these symptoms.

Androgen levels do not determine the type of PCOS symptoms in young females.

The BASP classification is effective for diagnosing pattern hair loss in Indian men and women.

Androgenic alopecia is male or female pattern baldness.

Testosterone can cause acne and male-pattern baldness, affects hair growth in men and women, and makes male skin more sensitive.

Early hair loss may indicate a higher risk of diabetes in young and middle-aged adults.

Adipose tissue and eccrine gland displacement are common in certain alopecias but don't help differentiate between them.

Finasteride effectively treats enlarged prostate and male baldness, improves symptoms of hirsutism in women, but doesn't work for acne, and may delay prostate cancer progression with few side effects.

Following hair transplant surgery, proper self-care is crucial for successful recovery and hair growth.

A young man with an unusual type of scarring hair loss suggests a possible new variant of a known scalp condition.

A woman with undifferentiated connective tissue disease was diagnosed with renal amyloidosis and carpal tunnel syndrome.

Facial care products are not linked to causing frontal fibrosing alopecia.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Androgenetic alopecia is less common in Chilean Mapuche than Caucasians, but more common than Asians, with racial differences in prevalence and types.

Genetics and hormones cause hair loss; finasteride treats it safely.

The updated SALT II tool offers a more precise way to measure scalp hair loss.

Low-level laser therapy may increase hair density in pattern hair loss.

The document concludes that central centrifugal cicatricial alopecia (CCCA) should be considered in African American men with vertex hair loss and scalp symptoms, and that prompt diagnosis and treatment can slow disease progression.

Many patients experienced hair loss after COVID-19, with women affected more, starting on average 49 days post-infection.

Low iron levels are linked to certain types of hair loss.

Androgenetic alopecia (AGA) is a common, hereditary hair loss condition that can be slowed but not permanently reversed with available therapies.

Frontal fibrosing alopecia can sometimes look like syphilitic hair loss.

Hair loss peaks in spring and regrowth in late summer, with pregnant females losing the most hair.

Dihydrotestosterone and 5α-Reductase play a role in hair loss and prostate health, and finasteride can increase hair growth in men without affecting sperm production, but it doesn't work for postmenopausal women with hair loss.

Various potential triggers may be causing the rise in frontal fibrosing alopecia, and avoiding these could help stop the disease's increase.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

Almost half of COVID-19 patients in Makkah, Saudi Arabia experienced increased hair loss, especially women and those with chronic diseases.

The most common causes of hair loss in a Nigerian hospital were discoid lupus erythematosus of the scalp and alopecia areata, and more research is needed to understand and address these issues.

Topical zinc-thymulin is safe and effective for treating male pattern baldness.